Verdict: Mixed

Key finding: No Intel-specific bad news. The slide started with reports that TSMC might help Musk's Terafab (Intel is the only named chip partner). Musk walked that back on 10/7 (TSMC "may sublease part of the Terafab if it wants, but nothing more"), and Intel says it stays in. The rest is a semis-wide pullback after INTC ran +56% in 8 weeks (81.79 on 7/29 to 127.44 on 9/24).

First INTC dive (no earlier rows).

Scorecard

Ticker Rev last Q Rev YoY last Q Rev YoY prior Q Gross margin (trend) Op margin EPS last Q vs yr ago P/S Mkt cap 1-mo price %
INTC $16,128M +25.4% +7.2% 41.5% (up from 27.5%) 12.3% -2.16 vs -0.67 (GAAP) 8.9x $510B -1.4%
AMD $11,536M +50.1% +37.9% 53.8% (flat) 17.3% 1.38 vs 0.54 23.3x $963B +16.7%
NVDA $96,221M +105.9% +85.2% 75.0% (flat) 66.2% 2.46 vs 1.08 18.1x $5,470B +2.5%
AVGO $29,591M +85.5% +47.9% 69.1% (up) 53.9% 2.68 vs 0.85 19.0x $1,689B -0.8%
TSM TWD 1,270,381M +36.1% +35.1% 67.7% (up) 60.3% 136.25 vs 72.60 (TWD/ADS-adj.) — $2,316B +4.1%

INTC is the laggard of the group on quality (41.5% gross / 12.3% op margin vs 54-75% / 17-66% for peers, GAAP loss) but the cheapest (8.9x sales vs 18-23x). Its revenue growth is accelerating (+7.2% to +25.4%), the turnaround the market is paying for. 1-mo price % is 9/9 to 10/9 close.

Move

Catalyst

Sector

Risks

Judgement

Mixed. The Terafab scare was partly an overreaction: Musk limited TSMC to a possible sublease and Intel remains a partner, and nothing changed in Intel's numbers (revenue +25% and accelerating, margins rising). But much of the -20% is a normal giveback of a +56% eight-week run inside a semis pullback, so there is no reason to chase at 101.

Sources